OVER DEZE AFLEVERING
BUFFALO, NY – September 17, 2026 – A new #commentary was #published in Volume 17 of Oncotarget on September 11, 2026, titled “Are both COVID-19 and COVID-19 vaccines associated with cancer?”
The paper was authored by Raphael Lataster, an independent researcher at the University of Sydney, and responds to a recent Oncotarget review by Charlotte Kuperwasser and Wafik S. El-Deiry examining published reports concerning cancer following COVID-19 vaccination or infection.
Lataster highlights research concerning potential associations between COVID-19 and cancer and discusses mechanisms proposed in the literature. He argues that similar mechanisms reported in connection with COVID-19 vaccination warrant consideration and further study.
The commentary also highlights differences in how evidence concerning COVID-19 vaccines and cancer has been evaluated in the scientific literature. He calls for the same evidentiary standards to be applied when considering potential links between COVID-19 infection, vaccination, and cancer.
“Such inquiries should proceed without preconceptions, applying the same evidentiary standards regardless of whether findings implicate infection, vaccination, or both.”
The commentary does not establish a causal relationship between COVID-19 vaccination and cancer. Rather, it calls for potential associations and biological mechanisms to be investigated without predetermined conclusions and with appropriate consideration of alternative explanations and the limitations of observational evidence.
DOI - https://doi.org/10.18632/oncotarget.28918
Correspondence to - Raphael Lataster - okaythennews@gmail.com (ORCID: https://orcid.org/0000-0002-6670-1702)
Preview video - https://www.youtube.com/watch?v=uSbIKNe3Hho
Sign up for free Altmetric alerts about this article - https://oncotarget.altmetric.com/details/email_updates?id=10.18632%2Foncotarget.28918
Subscribe for free publication alerts from Oncotarget - https://www.oncotarget.com/subscribe/
Keywords - cancer, COVID-19, COVID-19 vaccines, double standards
To learn more about Oncotarget, please visit https://www.oncotarget.com and connect with us:
Facebook - https://www.facebook.com/Oncotarget/
X - https://twitter.com/oncotarget
Instagram - https://www.instagram.com/oncotargetjrnl/
YouTube - https://www.youtube.com/@OncotargetJournal
LinkedIn - https://www.linkedin.com/company/oncotarget
Pinterest - https://www.pinterest.com/oncotarget/
Reddit - https://www.reddit.com/user/Oncotarget/
Spotify - https://open.spotify.com/show/0gRwT6BqYWJzxzmjPJwtVh
MEDIA@IMPACTJOURNALS.COM
The paper was authored by Raphael Lataster, an independent researcher at the University of Sydney, and responds to a recent Oncotarget review by Charlotte Kuperwasser and Wafik S. El-Deiry examining published reports concerning cancer following COVID-19 vaccination or infection.
Lataster highlights research concerning potential associations between COVID-19 and cancer and discusses mechanisms proposed in the literature. He argues that similar mechanisms reported in connection with COVID-19 vaccination warrant consideration and further study.
The commentary also highlights differences in how evidence concerning COVID-19 vaccines and cancer has been evaluated in the scientific literature. He calls for the same evidentiary standards to be applied when considering potential links between COVID-19 infection, vaccination, and cancer.
“Such inquiries should proceed without preconceptions, applying the same evidentiary standards regardless of whether findings implicate infection, vaccination, or both.”
The commentary does not establish a causal relationship between COVID-19 vaccination and cancer. Rather, it calls for potential associations and biological mechanisms to be investigated without predetermined conclusions and with appropriate consideration of alternative explanations and the limitations of observational evidence.
DOI - https://doi.org/10.18632/oncotarget.28918
Correspondence to - Raphael Lataster - okaythennews@gmail.com (ORCID: https://orcid.org/0000-0002-6670-1702)
Preview video - https://www.youtube.com/watch?v=uSbIKNe3Hho
Sign up for free Altmetric alerts about this article - https://oncotarget.altmetric.com/details/email_updates?id=10.18632%2Foncotarget.28918
Subscribe for free publication alerts from Oncotarget - https://www.oncotarget.com/subscribe/
Keywords - cancer, COVID-19, COVID-19 vaccines, double standards
To learn more about Oncotarget, please visit https://www.oncotarget.com and connect with us:
Facebook - https://www.facebook.com/Oncotarget/
X - https://twitter.com/oncotarget
Instagram - https://www.instagram.com/oncotargetjrnl/
YouTube - https://www.youtube.com/@OncotargetJournal
LinkedIn - https://www.linkedin.com/company/oncotarget
Pinterest - https://www.pinterest.com/oncotarget/
Reddit - https://www.reddit.com/user/Oncotarget/
Spotify - https://open.spotify.com/show/0gRwT6BqYWJzxzmjPJwtVh
MEDIA@IMPACTJOURNALS.COM
Engels
Verenigde Staten
TRANSCRIPTIE 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
OUDE AFLEVERINGEN ZOEKEN
Zoek naar eerdere afleveringen van Oncotarget.
ANDERE AFLEVERINGEN IN DEZE PODCAST
Cancer cells do not grow in isolation. Their ability to survive and form tumors depends partly on how they interact with immune cells in the surrounding tumor microenvironment. Melanoma is particularly responsive to immune-based mechanisms, making it important to understand the molecular processes …
BUFFALO, NY - September 8, 2026 – Oncotarget is proud to support the WIN 2026 Symposium, organized by the Worldwide Innovative Networking (WIN) Consortium, taking place October 2–3, 2026, at the Rhode Island Convention Center in Providence.
The two-day symposium, themed “Precision Oncology: Innova…
BUFFALO, NY – September 9, 2026 – A new #review was #published in Volume 17 of Oncotarget on September 8, 2026, titled “Re-expression of MHC-I to treat CNS cancers.”
The review examines emerging strategies to restore major histocompatibility complex class I (MHC-I) expression in cancers of the ce…
Head and neck squamous cell carcinoma (HNSCC) can return even after patients complete surgery, radiation, chemotherapy, or combinations of these treatments. Preventing recurrence therefore remains an important challenge in head and neck cancer care. Human papillomavirus (HPV), particularly HPV type…
Disclaimer: De podcast en de illustraties die op deze pagina zijn ingesloten, zijn afkomstig van Oncotarget Podcast, eigendom van de eigenaar en niet gelieerd aan of goedgekeurd door Listen Notes, Inc.
BEWERKEN
Bedankt voor uw hulp bij het up-to-date te houden van de podcast-database .